Free tool
FAERS Monitor: Numbrino
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209575 or its brand name (Numbrino, Cocaine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
65
Serious
64
98% of reports
Hospitalization
52
Death reported
7
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug abuse28
- toxicity to various agents26
- acute kidney injury11
- multiple organ dysfunction syndrome8
- rhabdomyolysis6
- cardiac arrest5
- cardiomyopathy5
- overdose5
- drug interaction4
- metabolic acidosis4
- pneumonia4
- substance abuse4
- unresponsive to stimuli4
- acute myocardial infarction3
- acute respiratory distress syndrome3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 12 |
| 2025 | 14 |
| 2026 | 31 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,094 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| substance abuseSignal | 4 | 159.1 | 61.6 | 480 |
| cardiomyopathySignal | 5 | 109.5 | 47.2 | 435 |
| drug abuseSignal | 28 | 108.9 | 82.3 | 2,896 |
| multiple organ dysfunction syndromeSignal | 8 | 91.4 | 47.8 | 629 |
| acute respiratory distress syndromeSignal | 3 | 54.9 | 18.2 | 109 |
| unresponsive to stimuliSignal | 4 | 50.2 | 19.4 | 147 |
| toxicity to various agentsSignal | 26 | 49.9 | 37.0 | 1,207 |
| rhabdomyolysisSignal | 6 | 46.6 | 21.7 | 224 |
| metabolic acidosisSignal | 4 | 40.5 | 15.7 | 117 |
| acute myocardial infarctionSignal | 3 | 32.9 | 10.9 | 64 |
| acute kidney injurySignal | 11 | 23.3 | 13.6 | 214 |
| cardiac arrestSignal | 5 | 19.6 | 8.4 | 71 |
| drug interactionSignal | 4 | 8.2 | 3.2 | 19 |
| overdoseSignal | 5 | 7.5 | 3.2 | 22 |
| pneumoniaSignal | 4 | 4.0 | 1.5 | 6 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.